Richard Schulick was named chief clinical officer at University of Rochester Medical Center, effective April 2026. Schulick will also become senior vice president for health system strategy, and vice dean for clinical affairs.
UCLA Health has received a $31 million commitment from Allen and Charlotte Ginsburg and their research foundation to advance biomedical research at the UCLA Research Park.
Sylvester Comprehensive Cancer Center, part of the University of Miami Health System and Miller School of Medicine, has announced the launch of the Sylvester Survivorship and Supportive Care Institute—a dedicated survivorship institute focused on meeting the full spectrum of needs of the growing cancer survivor population in South Florida.
Prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and treatment for patients of African ancestry.
The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading to cancer. But when p53 mutates, it can flip from protector to promoter of cancer.
On Nov. 6, FDA approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) for adults with high-risk smoldering multiple myeloma.
GSK and Empirico Inc. announced that they have entered into a worldwide exclusive license agreement for EMP-012, a highly selective first- and potentially best-in-class siRNA, a type of oligonucleotide.
GSK5764227 (GSK’227), a B7-H3-targeted antibody-drug conjugate, has received Orphan Drug Designation from the European Medicines Agency for the treatment of pulmonary neuroendocrine carcinoma, a category of cancer that includes small-cell lung cancer.
The National Cancer Institute approved the following clinical research study last month.
Love them or hate them, site visits have been a part of the culture of NCI-designated cancer centers for decades, shaping the process for admitting members to the elite club and influencing internal politics within institutions.
